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Malaria is one of the major public health 
problems in more than 90 countries, 
inhabited by a total of some 2.4 billion 
people, representing about 40% of the 
world’s population (WHO, 2004).
Malaria endemic areas
Amodiaquine (AQ) has been recently introduced into 
artemisinin-based combination therapy for use in 
malaria control programmes and as a first line treatment 





Besides amodiaquine, CYP2C8 also metabolizes several 










CYP2C8 is mainly expressed in the 
liver, as well as in various 
extrahepatic tissues such as the 
vascular smooth muscles (Klose et 
al., 1999; Fleming, 2001).
The main CYP2C8 polymorphisms known code for the 
amino acid changes I269F, R139K, K399R and I264M. 





A glance at Guinea-Bissau
Source: travelpod.com
A glance at Guinea-Bissau
Source: travelpod.com
Canchungo hospital, Guinea-Bissau             Source: www.kalpana.it
RESEARCH OBJECTIVES
• To study CYP2C8 alleles among malaria patients from 
Guinea Bissau
• To assist policy-makers in the management of malaria in 
Guinea-Bissau
• To generate pharmacogenetic data for the evaluation of 
treatment and drug dispension
• To contribute findings to other databases and bio-banks 
within and outside Europe
• To allow further comparisons with other populations 
previously characterized in the Center for Molecular and 
Structural Biomedicine, Universidade do Algarve, Portugal
MATERIALS AND METHODS
Subjects : 91 randomly selected malaria patients from Guinea-
Bissau 
DNA Extraction
Polymerase Chain Reaction (PCR)
Restricted Fragment Length Polymorphism (RFLP)
Statistical Analysis
Allelic frequencies determined - PM alleles? EM alleles? etc
RESULTS
1       2       3     4       5      6      7       8      9    10    11    12
Lane 1: fX174 DNA/HinfI Marker; Lane 2: Homozygous mutant for the CYP2C8*2
allele; Lane 3, 5, 6: Homozygous wild-type for the CYP2C8*2 allele; Lane 4: 
Heterozygous for for CYP2C8*2 allele; Lanes 7 to 11: Homozygous wild-type bands for 





CYP2C8 allele frequencies obtained:
CYP2C8*2 = 0.2418
CYP2C8*3 = 0.3242
CYP2C8*4 = not detected 







• Comparison of CYP2C8
genotypes with other populations
• Comparison of CYP2C8 allele 
frequencies with other 
populations
• Comparison of CYP2C8 allele 
frequencies between malaria 
patients from GB and Zanzibar
DISCUSSION
Comparison of CYP2C8 allele frequencies between malaria 
patients from Guinea-Bissau and Zanzibar
• Higher prevalence of the 
CYP2C8*3 allele in West 
Africa 




CYP2C8 genotype comparison with 5 other populations
Comparison of CYP2C8 allele frequencies with other populations
CONCLUSION
• Highest frequency of CYP2C8 variant alleles ever recorded 
in a population of African descent.
• High occurrence of CYP2C8*2 and CYP2C8*3 alleles 
among malaria patients in Guinea-Bissau.
• This implies a high incidence of CYP2C8 poor metabolizer 
alleles among malaria patients in Guinea-Bissau who may be 
at a greater risk of adverse effects compared to other 
populations previously characterized.
FUTURE RECOMMENDATIONS
• Further investigation 
taking into account the 
effects of CYP2C8
metabolism on the 
pharmacokinetics of 
antimalarials 
• Study of polymorphisms 
in healthy subjects
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